Database release
In this release, we add two recent precision oncology approvals from the FDA.
Posts are organized into categories for ease of navigation:
In this release, we add two recent precision oncology approvals from the FDA.
In this release, we have removed neoantigen burden as a cataloged feature type and combined Silencing with Knockdown feature types. We additionally expanded upon fields required for each feature type within our S.O.P.
The following assertions sourced from recent FDA approvals were added to the Molecular Oncology Almanac in this release -